~Most recent Study HUGE! ~09/25/13http://www.ncbi.nlm.nih.gov/pubmed/24071814 ~Application of Sweat Patch Screening for 16 Drugs and Metabolites Using a Fast and Highly Selective LC-MS/MS Method.
~Very, Very, Interesting ~ PATENT US 20070298132 A1 along with major studies published on National Center for Biotechnology Information, U.S. National Library of Medicine Berberine as a selective lung cancer agent US 20070298132 A1 Original Assignee - Pharmchem Inc. PCHM Owner name: MICRON TECHNOLOGY, INC.,IDAHO MU MRK http://investorshub.advfn.com/boards/read_msg.aspx?message_id=93416214
~International Exposure This model is being implemented in ever increasing number of countries in the Hemisphere thanks to the leadership and commitment of the various OAS member states, and the direct support of the Executive Secretariat of the Inter-American Drug Abuse Control Commission of the OAS.
Such companies are chronically overlooked by Wall Street. Wall Street coverage is positively correlated to a company's market capitalization, leaving smaller-cap stocks with less coverage and greater opportunity for mispricing. Institutional investors often spend little effort researching micro-cap and small-cap opportunities because of their limited impact on major indices. This lack of coverage allows disciplined Investors to buy stocks that trade for less than their intrinsic value.
Until the regulators do a better job of policing the stock market in general, and particularly the world of penny stocks, “buyer beware” will continue to be the golden rule of investing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.